MedDataX Logo

Surgical Telemedicine in the COVID-19 Pandemic Era

NCT ID: NCT04376710

Last Updated: 2020-10-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-01

Study Completion Date

2020-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current COVID-19 pandemic has caused delays in initial or follow-up encounters between surgical patients and physicians. While this delay allows for resource allocation to those most severely affected by the pandemic, surgeons are faced with potential important delays in diagnosis and the expanding backlog of elective cases and initial evaluations.

This project will assess surgeon and patient telemedicine perspectives. Pre-pandemic views on telemedicine among a cohort of surgeons will be obtained and compared to views at 3 months from the peak of the pandemic. Patients will be surveyed following telemedicine appointments with an anonymous questionnaire to learn about patient receptiveness to telemedicine. Barriers to implementation will be addressed throughout the duration of the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgeons

Completion of pre-pandemic survey

Intervention Type OTHER

Surgeons will take a pre-pandemic survey to determine surgeon perceptions to telemedicine and barriers to implementation.

Completion of survey after peak of pandemic

Intervention Type OTHER

Surgeons will take another survey after the peak of pandemic to determine surgeon perceptions to telemedicine and barriers to implementation.

Patients

Completion of post telemedicine encounter survey

Intervention Type OTHER

Patients will take a post telemedicine encounter survey to determine patient perceptions to telemedicine and barriers to implementation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Completion of pre-pandemic survey

Surgeons will take a pre-pandemic survey to determine surgeon perceptions to telemedicine and barriers to implementation.

Intervention Type OTHER

Completion of survey after peak of pandemic

Surgeons will take another survey after the peak of pandemic to determine surgeon perceptions to telemedicine and barriers to implementation.

Intervention Type OTHER

Completion of post telemedicine encounter survey

Patients will take a post telemedicine encounter survey to determine patient perceptions to telemedicine and barriers to implementation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Surgical faculty at participating institutions will receive surveys regarding telemedicine early in the start of the study to assess baseline perceptions. These same group of surgeons will receive subsequent surveys 3 months after the peak of the pandemic to evaluate telemedicine perceptions following a rapid implementation and adoption of telemedicine.
2. Surgical patients evaluated from the start of the study through a 6-month period will be included in the study. They will have the option after each telemedicine encounter to complete an anonymous survey regarding perceptions to this technology.

Exclusion Criteria

1. No exclusions for surgical faculty are identified. Accrual of data from this group will be limited only by response rates to administered surveys.
2. Exclusions for surgical patients will include the inability to access the technology required for a telemedicine consultation (e.g.: absence of a camera enabled smartphone, absence of a required internet or cellular connection to perform a telemedicine encounter). The investigators will keep a list of reasons for the inability to perform a telemedicine encounter to identify the barriers to implementation among patients.
Minimum Eligible Age

31 Days

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Colorado, Denver

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Hospital Colorado

Aurora, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Diaz-Miron J, Ogle S, Kaizer A, Acker SN, Rove KO, Inge TH. Surgeon, patient, and caregiver perspective of pediatric surgical telemedicine in the COVID-19 pandemic era. Pediatr Surg Int. 2022 Feb;38(2):241-248. doi: 10.1007/s00383-021-05016-8. Epub 2021 Sep 22.

Reference Type DERIVED
PMID: 34550442 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20-1177

Identifier Type: -

Identifier Source: org_study_id